Platform for post-authorisation studies registered as EU trade mark By Anna Jurczynska | August 7, 2017 Posted in Recent News and tagged ema, EU PAS Register, European Medicines Agency, European Union trade mark, EUTM, Intellectual Property ← FDA Tackles Drug Competition to Improve Patient AccessEMA prepares for Brexit →